Literature DB >> 10494134

Development and evaluation of a competitive time-resolved immunofluorometric assay for the estrogen-regulated protein pS2.

R S Rosenberg Zand1, D J Jenkins, E P Diamandis.   

Abstract

We have developed a competitive assay to measure the estrogen-regulated protein pS2. A monoclonal pS2 antibody (mAb) and a biotinylated pS2 peptide are used, with time-resolved fluorometry as a detection technique. The assay has a detection limit of 16 ng/mL and is precise (within-run and day-to-day Cvs 3-12%). We used this assay to determine steroid hormone activity of six steroids in cell culture, both in terms of time course and dose response. pS2 concentrations in the tissue culture supernatant of the BT-474 breast carcinoma cell line were significantly higher when estradiol was the stimulating steroid. There was a significant time course and dose response observed for estradiol, but not for the other steroids. The availability of a sensitive, reliable, and convenient method for quantifying pS2 will allow for many research applications including the screening of natural and synthetic compounds for putative estrogenic activity. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10494134      PMCID: PMC6807710          DOI: 10.1002/(sici)1098-2825(1999)13:5<241::aid-jcla9>3.0.co;2-u

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  27 in total

1.  Multiple labeling and time-resolvable fluorophores.

Authors:  E P Diamandis
Journal:  Clin Chem       Date:  1991-09       Impact factor: 8.327

Review 2.  Trefoil proteins: their role in normal and malignant cells.

Authors:  F E May; B R Westley
Journal:  J Pathol       Date:  1997-09       Impact factor: 7.996

3.  Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line.

Authors:  P Masiakowski; R Breathnach; J Bloch; F Gannon; A Krust; P Chambon
Journal:  Nucleic Acids Res       Date:  1982-12-20       Impact factor: 16.971

4.  Prediction of relapse and survival in breast cancer patients by pS2 protein status.

Authors:  J A Foekens; M C Rio; P Seguin; W L van Putten; J Fauque; M Nap; J G Klijn; P Chambon
Journal:  Cancer Res       Date:  1990-07-01       Impact factor: 12.701

5.  Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues.

Authors:  N A Wright; R Poulsom; G W Stamp; P A Hall; R E Jeffery; J M Longcroft; M C Rio; C Tomasetto; P Chambon
Journal:  J Pathol       Date:  1990-12       Impact factor: 7.996

6.  Enzymatically amplified time-resolved fluorescence immunoassay with terbium chelates.

Authors:  T K Christopoulos; E P Diamandis
Journal:  Anal Chem       Date:  1992-02-15       Impact factor: 6.986

7.  Trefoil peptides promote epithelial migration through a transforming growth factor beta-independent pathway.

Authors:  A Dignass; K Lynch-Devaney; H Kindon; L Thim; D K Podolsky
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

8.  Steroid hormone regulation of prostate-specific antigen gene expression in breast cancer.

Authors:  N Zarghami; L Grass; E P Diamandis
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

9.  pS2 transfection of murine adenocarcinoma cell line 410.4 enhances dispersed growth pattern in a 3-D collagen gel.

Authors:  R Williams; G W Stamp; C Gilbert; M Pignatelli; E N Lalani
Journal:  J Cell Sci       Date:  1996-01       Impact factor: 5.285

10.  pS2 protein: a marker improving prediction of response to neoadjuvant tamoxifen in post-menopausal breast cancer patients.

Authors:  I Soubeyran; N Quénel; J M Coindre; F Bonichon; M Durand; J Wafflart; L Mauriac
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.